Trajan tips for business sustainability at AusMedtech 2016

Trajan tips for business sustainability at AusMedtech 2016

August 15, 2016

Trajan Scientific and Medical (Trajan) Chief Executive Officer Stephen Tomisich, delivered the opening plenary at AusMedtech 2016 in Adelaide from 10 - 11 May, discussing how to grow and sustain scientific and medical device companies.

Mr Tomisich's address covered three key pillars to Trajan's business sustainability; foundation, activity, and risk mitigation.

View the full plenary video below, or on Trajan's YouTube channel.

 

More information
www.ausmedtech.com.au

Media contact information
Tel: +44 (0) 1244 403 100
media@trajanscimed.com




Also in News

Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.
Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.

February 15, 2023

Trajan Scientific and Medical announces the completion to acquire specialized software business, HDExaminer, from California-based, Sierra Analytics, Inc.

Read More

Trajan collaborates with Monash University for the development of HDX training centre
Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Trajan Scientific and Medical with Monash University would like to announce a collaboration for the development of an HDX training centre at Monash University's Proteomics and Metabolomics Facility (MPMF). This collaboration will provide the university with access to a Trajan HDX system and allow Trajan to provide HDX training to the proteomics community in the region.

Read More

Baker Institute research leads to simple tests for heart and diabetes disease
Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Collaboration has been key to a global health innovation to counter cardiovascular disease. One of Australia’s leading research facilities, the Baker Heart and Diabetes Institute, had the technology to potentially revolutionise testing for heart disease and diabetes, using just a single drop of blood. All it lacked for this global breakthrough was commercial nous, developmental infrastructure and marketing know-how. On the other hand, Trajan Scientific and Medical, a Melbourne-based ASX biotech company, had the technology and expertise to take products to market.

Read More